CXCL10 and central nervous system cancer: Amankulor et al. reported that the T-cell attracting chemokines CXCL9, CXCL10, CCL2, and CCL12 are downregulated in isocitrate dehydrogenase (IDH)-mutated gliomas, resulting in the repression of immune cell infiltration (60).